Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for XPR. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: XPR is a Strong Sell candidate.
XPR stock price ended at $0.002261 on 星期二, after dropping 0.68%
On Mar 31, 2026 00:00, the price of XPR fell by 0.68%, dropping from $0.002264 to $0.002261 with 24h trading volume reaching $1.3M XPR.